Amelioratory Effect of Nanoconjugated Vancomycin on Spleen during VRSA-Induced Oxidative Stress
Figure 4
Lipid peroxidation (MDA) level and protein carbonyl (PC) contents in spleen of control, VRSA-infected, and nanoconjugated-vancomycin-treated group. Values are expressed as mean ± SEM, . *indicates significant difference () compared to control group. #indicates significant difference () compared to VRSA-infected group.